Pierre Schembri-Wismayer

Pierre Schembri-Wismayer

Auto-generated profile, based on publicly available information

Pierre Schembri-Wismayer

Department of Anatomy, Faculty of Medicine and Surgery, University of Malta, MSD 2080 Msida, Malta

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2015 in Acta Biomaterialia
Verified
Journal Article
Closed access
RGRuben Gatt
Ruben Gatt
MWMichelle Vella Wood
Michelle Vella Wood
AGAlfred Gatt
Alfred Gatt
Francis ZarbFrancis Zarb
Francis Zarb
Cynthia FormosaCynthia Formosa
Cynthia Formosa
Joseph N. GrimaJoseph N. Grima
Joseph N. Grima

1 June 2016 in BBA Clinical
Verified
Journal Article
Open access
AJAbdo Jurjus
Abdo Jurjus
AEAssad Eid
Assad Eid
SKSahar Al Kattar
Sahar Al Kattar
MZMarie Noel Zeenny
Marie Noel Zeenny
AGAlice Gerges-Geagea
Alice Gerges-Geagea
RJRosalyn A. Jurjus
Rosalyn A. Jurjus
The co-occurrence of the three disease entities, inflammatory bowel disease (IBD), colorectal cancer (CRC), type 2diabetes mellitus (T2DM) along with inflammation and dismicrobism has been frequently reported. Some authors have even suggested that dysbiosis could be the link through a molecular crosstalk of multiple inflammatory loops including TGFβ, NFKB, TNFα and ROS among others. This review focuses on the inflammatory process along with the role of microbiota in the pathophysiology of the three diseases. The etiology of IBD is multifactorial, and like CRC and T2DM, it is associated with a widespread and sustained GI inflammation and dismicrobism, whereby an array of pro-inflammatory mediators and other related biomolecules are up-regulated, both locally and systematically. Such a persistent or an inadequately resolved chronic inflammation may be a causative agent, in the presence other factors, leading to several pathologies such as IBD, CRC and T2DM. TGFβ plays a crucial role in pancreatic β cell malfunctioning as glucotoxicity stimulates its signaling cascade through smad 3, IL-6 and epithelial to mesenchymal transition. Such a cascade could lead to macrophages and other cells recruitment, inflammation, then IBD and CRC. NFkB is also another key regulator in the crosstalk among the pathways leading to the three disease entities. It plays a major role in linking inflammation to cancer development through its ability to up regulate several inflammatory and tumor promoting cytokines like: IL-6, IL-1 α and TNF α, as well as genes like BCL2 and BCLXL. It activates JAK/STAT signaling network via STAT3 transcription factors and promotes epithelial to mesenchymal transition. It also increases the risk for T2DM in obese people. In brief, NFKB is a matchmaker between inflammation, IBD, cancer and diabetes. In addition, TNFα plays a pivotal role in systemic inflammation. It is increased in the mucosa of IBD patients and has a central role in its pathogenesis. It also activates other signaling pathways like NFKB and MAPK leading to CRC. It is also overexpressed in the adipose tissues of obese patients thus linking it to T2DM, chronic inflammation and consequently CRC. On the other hand, increasing evidence suggests that dysbiosis plays a role in initiating, maintaining and determining the severity of IBD. Actually, among its functions, it modulates genotoxic metabolites which are able to induce CRC, a fact proven to be sustained by stool transfer from patients with CRC. Probiotics, however, may actively prevent CRC as well as IBD and results in a significant decrease in fasting glycemia in T2DM patients. In conclusion, IBD, CRC and T2DM are commonly occurring interrelated clinical problems. They share a common basis influenced by an inflammatory process, an imbalance in intestinal microbiota, and a crosstalk between various signaling pathways. Would probiotics interrupt the crosstalk or orient it in the physiological direction?

Verified
Journal Article
Open access
PDF file
LBLian Bonnici
Lian Bonnici
SSsherif suleiman
sherif suleiman
PSPierre Schembri-Wismayer
Pierre Schembri-Wismayer
ACAnalisse Cassar
Analisse Cassar
Chronic wounds fail to achieve complete closure and are an economic burden to healthcare systems due to the limited treatment options and constant medical attention. Chronic wounds are characterised by dysregulated signalling pathways. Research has focused on naturally derived compounds, stem-cell-based therapy, small molecule drugs, oligonucleotide delivery nanoparticles, exosomes and peptide-based platforms. The phosphoinositide-3-kinase (PI3K)/protein kinase B (AKT), Wingless-related integration (Wnt)/β-catenin, transforming growth factor-β (TGF-β), nuclear factor erythroid 2–related factor 2 (Nrf2), Notch and hypoxia-inducible factor 1 (HIF-1) signalling pathways have critical roles in wound healing by modulating the inflammatory, proliferative and remodelling phases. Moreover, several regulators of the signalling pathways were demonstrated to be potential treatment targets. In this review, the current research on targeting signalling pathways under chronic wound conditions will be discussed together with implications for future studies.

17 October 2011 in Gynecological Endocrinology
Verified
Journal Article
Closed access
KSKeith Sacco
Keith Sacco
MPMark Portelli
Mark Portelli
JPJoël Pollacco
Joël Pollacco
PSPierre Schembri-Wismayer
Pierre Schembri-Wismayer
JCJean Calleja-Agius
Jean Calleja-Agius
Endometriosis is a leading cause of infertility in women of reproductive age. It involves the occurrence of endometrial tissue outside the uterine endometrium, mainly in the peritoneal cavity. Prostaglandin E2 is up regulated in the peritoneal cavity in endometriosis and is produced by macrophages and ectopic endometrial cells. This prostaglandin is involved in the pathophysiology of the disease and elicits cell signals via four receptor types. Prostaglandin E2 increases estrogen synthesis by up regulating steroidogenic acute regulatory protein (StAR) and aromatase. It inhibits apoptosis and up regulates fibroblast growth factor-9 (FGF-9) promoting cell proliferation. Prostaglandin E2 affects leukocyte populations and promotes angiogenesis through its effect on estrogen and up regulation of vascular endothelial growth factor (VEGF). Dienogest is a synthetic progestin targeting expression of genes involved in prostaglandin synthesis.

31 May 2013 in Climacteric
Verified
Journal Article
Closed access
PDF file
MBM. Borg
M. Borg
SBS. Brincat
S. Brincat
GCG. Camilleri
G. Camilleri
PSP. Schembri-Wismayer
P. Schembri-Wismayer
MBM. Brincat
M. Brincat
JCJean Calleja-Agius
Jean Calleja-Agius
Cutaneous aging is one of the major noticeable menopausal complications that most women want to fight in their quest for an eternally youthful skin appearance. It may contribute to some maladies that occur in aging which, despite not being life-threatening, affect the well-being, psychological state and quality of life of aged women. Skin aging is mainly affected by three factors: chronological aging, decreased levels of estrogen after menopause, and environmental factors. Aged skin is characterized by a decrease in collagen content and skin thickness which result in dry, wrinkled skin that is easily bruised and takes a longer time to heal. Cytokines play a crucial role in the manifestation of these features of old skin. The pro-inflammatory cytokine tumor necrosis factor-alpha inhibits collagen synthesis and enhances collagen degradation by increasing the production of MMP-9. It also lowers the skin immunity and thus increases the risk of cutaneous infections in old age. Deranged levels of several interleukins and interferons also affect the aging process. The high level of CCN1 protein in aged skin gives dermal fibroblasts an ‘age-associated secretory phenotype’ that causes abnormal homeostasis of skin collagen and leads to the loss of the function and integrity of skin. Further research is required especially to establish the role of cytokines in the treatment of cutaneous aging.

1 April 2016 in Journal of Endodontics
Verified
Journal Article
Closed access
AMAmir T. Moinzadeh
Amir T. Moinzadeh
CPCarlos Aznar Portoles
Carlos Aznar Portoles
PWPierre Schembri Wismayer
Pierre Schembri Wismayer
Josette CamilleriJosette Camilleri
Josette Camilleri